THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Amanda Sharpe to Substance-Related Disorders

Back to Details
This is a "connection" page, showing publications Amanda Sharpe has written about Substance-Related Disorders.
Amanda Sharpe
Connection Strength
0.483
Substance-Related Disorders
  1. Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation. PLoS One. 2017; 12(7):e0180710.
    View in: PubMed
    Score: 0.483
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES